PK Comparison of GL2701 With Finasteride and Tamsulosin in Combination

NCT01829893 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

26

Enrollment

OTHER

Sponsor class

Conditions

Benign Prostatic Hyperplasia (BPH)

Interventions

DRUG: In combination of 0.2mg finasteride and 5mg tamsulosin
DRUG: GL2701 capsule

Sponsor

Korea University Anam Hospital

Collaborators

[object Object]